TD Cowen Reaffirms Buy Rating, $655 Target on Microsoft Citing AI Strength
TD Cowen reaffirmed a Buy rating and a $655 price target on Microsoft (NASDAQ:MSFT), expressing confidence in the company's artificial intelligence capabilities following announcements at its Ignite conference.
The firm noted that Microsoft advanced its AI strategy with new products designed to democratize intelligence access, further embed AI into workplace functions, and solve challenges related to implementation. Key announcements included new Intelligence and Agent 365 control planes, which help anchor AI in enterprise data environments and provide monitoring tools for governance and return on investment.
TD Cowen also pointed to Microsoft's new partnership with Anthropic as a strategic positive. The analyst believes the company holds a leading position across multiple layers of the AI stack.
According to the firm, Microsoft's integration across its 365 applications and Fabric data platform, along with native connections to partner data stores, positions it to offer end-to-end infrastructure for AI agents. The analyst identified Agent 365 and Foundry IQ as important tools for overcoming organizational hurdles like security concerns, governance issues, and difficulties in measuring returns.
Microsoft Corporation (MSFT) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.